Allakos (ALLK) Stock Forecast, Price Target & Predictions
ALLK Stock Forecast
Allakos stock forecast is as follows: an average price target of $109.50 (represents a 16746.15% upside from ALLK’s last price of $0.65) and a rating consensus of 'Buy', based on 4 wall street analysts offering a 1-year stock forecast.
ALLK Price Target
The average price target for Allakos (ALLK) is $109.50 based on 1-year price targets from 4 Wall Street analysts in the past 3 months, with a price target range of $218.00 to $1.00. This represents a potential 16746.15% upside from ALLK's last price of $0.65.
ALLK Analyst Ratings
According to 4 Wall Street analysts, Allakos's rating consensus is 'Buy'. The analyst rating breakdown for ALLK stock is 0 'Strong Buy' (0.00%), 3 'Buy' (75.00%), 1 'Hold' (25.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Allakos Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Jul 18, 2024 | Farzin Haque | Jefferies | $1.00 | $0.82 | 21.43% | 53.85% |
| Jan 17, 2024 | Kevin Strang | Jefferies | $3.00 | $1.19 | 152.10% | 361.54% |
| Oct 15, 2021 | Brian Cheng | Cantor Fitzgerald | $218.00 | $107.48 | 102.83% | 33438.46% |
The latest Allakos stock forecast, released on Jul 18, 2024 by Farzin Haque from Jefferies, set a price target of $1.00, which represents a 21.43% increase from the stock price at the time of the forecast ($0.82), and a 53.85% increase from ALLK last price ($0.65).
Allakos Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 1 | 2 |
| Avg Price Target | - | $1.00 | $2.00 |
| Last Closing Price | $0.65 | $0.65 | $0.65 |
| Upside/Downside | -100.00% | 53.85% | 207.69% |
In the current month, the average price target of Allakos stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Allakos's last price of $0.65. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Oct 11, 2024 | Cowen & Co. | Hold | Hold | Hold |
| Oct 11, 2024 | Piper Sandler | Overweight | Overweight | Hold |
| Jun 26, 2024 | Cowen & Co. | Hold | Hold | Hold |
| Jun 26, 2024 | Piper Sandler | Overweight | Overweight | Hold |
| Dec 18, 2023 | William Blair | - | Outperform | Upgrade |
| May 11, 2023 | Jefferies | - | Buy | Upgrade |
Allakos's last stock rating was published by Cowen & Co. on Oct 11, 2024. The company gave ALLK a "Hold" rating, the same as its previous rate.
Allakos Financial Forecast
Allakos Revenue Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - |
| Avg Forecast | - | - | - | - | - | - | - |
| High Forecast | - | - | - | - | - | - | - |
| Low Forecast | - | - | - | - | - | - | - |
| # Analysts | - | - | - | - | - | - | - |
| Surprise % | - | - | - | - | - | - | - |
Allakos's average Quarter revenue forecast for undefined based on undefined analysts is $NaN, with a low forecast of $NaN, and a high forecast of $NaN. ALLK's average Quarter revenue forecast represents a NaN% decrease compared to the company's last Quarter revenue of $NaN (undefined).
Allakos EBITDA Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | - | - |
| EBITDA | - | - | - | - | - | - | - |
| Avg Forecast | - | - | - | - | - | - | - |
| High Forecast | - | - | - | - | - | - | - |
| Low Forecast | - | - | - | - | - | - | - |
| Surprise % | - | - | - | - | - | - | - |
undefined analysts predict ALLK's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Allakos's previous annual EBITDA (undefined) of $NaN.
Allakos Net Income Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | - | - |
| Net Income | - | - | - | - | - | - | - |
| Avg Forecast | $-21.72M | $-18.17M | $-12.41M | $-12.71M | $-20.25M | $-22.00M | $-29.48M |
| High Forecast | $-21.72M | $-18.17M | $-12.41M | $-12.71M | $-20.25M | $-18.00M | $-29.48M |
| Low Forecast | $-21.72M | $-18.17M | $-12.41M | $-12.71M | $-20.25M | $-25.00M | $-29.48M |
| Surprise % | - | - | - | - | - | - | - |
Allakos's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. ALLK's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
Allakos SG&A Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | - | - |
| SG&A | - | - | - | - | - | - | - |
| Avg Forecast | - | - | - | - | - | - | - |
| High Forecast | - | - | - | - | - | - | - |
| Low Forecast | - | - | - | - | - | - | - |
| Surprise % | - | - | - | - | - | - | - |
Allakos's average Quarter SG&A projection for undefined is $NaN, based on undefined Wall Street analysts, with a range of $NaN to $NaN. The forecast indicates a NaN% fall compared to ALLK last annual SG&A of $NaN (undefined).
Allakos EPS Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | - | - |
| EPS | - | - | - | - | - | - | - |
| Avg Forecast | $-0.24 | $-0.20 | $-0.14 | $-0.14 | $-0.23 | $-0.25 | $-0.33 |
| High Forecast | $-0.24 | $-0.20 | $-0.14 | $-0.14 | $-0.23 | $-0.20 | $-0.33 |
| Low Forecast | $-0.24 | $-0.20 | $-0.14 | $-0.14 | $-0.23 | $-0.28 | $-0.33 |
| Surprise % | - | - | - | - | - | - | - |
According to undefined Wall Street analysts, Allakos's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to ALLK previous annual EPS of $NaN (undefined).
Allakos Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| ALLK | Allakos | $0.65 | $109.50 | 16746.15% | Buy |
| SGMO | Sangamo Therapeutics | $0.94 | $12.00 | 1176.60% | Hold |
| FATE | Fate Therapeutics | $3.22 | $39.75 | 1134.47% | Buy |
| ALLO | Allogene Therapeutics | $2.69 | $29.00 | 978.07% | Buy |
| SPRO | Spero Therapeutics | $1.29 | $10.00 | 675.19% | Buy |
| CTMX | CytomX Therapeutics | $1.16 | $5.77 | 397.41% | Buy |
| HRTX | Heron Therapeutics | $1.82 | $7.00 | 284.62% | Buy |
| SANA | Sana Bio | $4.06 | $12.00 | 195.57% | Buy |
| ARVN | Arvinas | $27.04 | $75.36 | 178.70% | Buy |
| APLS | Apellis Pharmaceuticals | $27.92 | $76.13 | 172.67% | Buy |
| DAWN | Day One Biopharmaceuticals | $15.08 | $38.80 | 157.29% | Buy |
| NXTC | NextCure | $1.45 | $3.00 | 106.90% | Buy |
| ASMB | Assembly Biosciences | $18.10 | $35.50 | 96.13% | Buy |
| RARE | Ultragenyx Pharmaceutical | $56.77 | $108.14 | 90.49% | Buy |
| RCUS | Arcus Biosciences | $18.24 | $34.29 | 87.99% | Buy |
| ANNX | Annexon | $7.63 | $14.00 | 83.49% | Buy |
| CRBU | Caribou Biosciences | $1.94 | $3.00 | 54.64% | Buy |
| KURA | Kura Oncology | $18.09 | $25.67 | 41.90% | Buy |
| BPMC | Blueprint Medicines | $86.00 | $105.62 | 22.81% | Buy |
| CRNX | Crinetics Pharmaceuticals | $58.92 | $70.14 | 19.04% | Buy |
| ATRA | Atara Biotherapeutics | $9.38 | $10.50 | 11.94% | Sell |
| RVMD | Revolution Medicines, Inc. Warrant | $50.00 | $53.83 | 7.66% | Buy |
| KRTX | Karuna Therapeutics | $329.83 | $257.50 | -21.93% | Buy |
| GTHX | G1 Therapeutics | $7.15 | $4.50 | -37.06% | Buy |
ALLK Forecast FAQ
Is Allakos a good buy?
Yes, according to 4 Wall Street analysts, Allakos (ALLK) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 3 'Buy' recommendations, accounting for 75.00% of ALLK's total ratings.
What is ALLK's price target?
Allakos (ALLK) average price target is $109.5 with a range of $1 to $218, implying a 16746.15% from its last price of $0.65. The data is based on 4 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Allakos stock go up soon?
According to Wall Street analysts' prediction for ALLK stock, the company can go up by 16746.15% (from the last price of $0.65 to the average price target of $109.5), up by 33438.46% based on the highest stock price target, and up by 53.85% based on the lowest stock price target.
Can Allakos stock reach $1?
ALLK's average twelve months analyst stock price target of $109.5 supports the claim that Allakos can reach $1 in the near future.
What are Allakos's analysts' financial forecasts?
Allakos's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $0 (high $0, low $0), average EBITDA is $0 (high $0, low $0), average net income is $-71.723M (high $-67.723M, low $-74.722M), average SG&A $0 (high $0, low $0), and average EPS is $-0.809 (high $-0.764, low $-0.843). ALLK's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $0 (high $0, low $0), average EBITDA is $0 (high $0, low $0), average net income is $-65.005M (high $-65.005M, low $-65.005M), average SG&A $0 (high $0, low $0), and average EPS is $-0.733 (high $-0.733, low $-0.733).